References
- Barrigon S., Tamargo J., De Jalon P. D. Cinetica de distribution de la mexiletina (MXT) en la rata. Archives de Farmacologia Toxicologia 1983; 9: 65–76
- Gibaldi M., Perrier D. Pharmacokinetics. Marcel Dekker, New York 1982
- Grech-Belanger O., Turgeon J., Gilbert M. Stereoselective disposition of mexiletine enantiomers in man. British Journal of Clinical Pharmacology 1986; 21: 481–487
- Haselbarth V., Doevendans J. E., Wolf J. E. Kinetics and bioavailability of mexiletine in healthy subjects. Clinical Pharmacology and Therapeutics 1981; 29: 729–736
- Igwemezie L., Kerr C. R., McErlane K. M. The pharmacokinetics of mexiletine enantiomers in humans. Xenobiotica 1989; 19: 677–682
- Kawashima K., Levy A., Spector S. Stereospecific radioimmuno-assay for propranolol isomers. Journal of Pharmacology and Experimental Therapeutics 1976; 196: 517–523
- McErlane K. M., Igwemezie L., Kerr C. R. Stereoselective analysis of the enantiomers of mexiletine by high-performance liquid chromatography using fluorescence detection and study of their Stereoselective disposition in man. Journal of Chromatography (Biomedical Applications) 1987; 415: 335–346
- Palileo E. V., Welch W., Hoff J., Strasberg B., Bau Bernfeind R. A., Swiryn S., Coelho A., Rosen K. M. Lack of effectiveness of oral mexiletine in patients with drug refractory paroxysmal sustained ventricular tachycardia. American Journal of Cardiology 1982; 50: 1075–1081
- Prescott L. F., Clements J. A., Pottage A. Absorption, distribution and elimination of mexiletine. Postgraduate Medical Journal 1977; 53(Suppl. 1)50–55
- Sedman A. J., Wagner J. G. AUTOAN: A Decision-making Pharmacokinetic Computer Program. Publication Distribution Services, Michigan 1976
- Statistical Consultants, Inc. PCNONLIN and NONLIN84: Software for the statistical analysis of nonlinear models. American Statistician 1986; 40: 1
- Tocco D. J., Hooke K. F., Duncan A. E. W. Stereospecific binding of timolol, a betaadrenergic blocking agent. Drug Metabolism and Disposition 1976; 4: 323–329
- Uprichard A. C. G., Harron D. W. Atenolol and not mexiletine, protects against stimulus induced ventricular tachycardia in a chronic canine model. British Journal of Pharmacology 1989; 96: 220–226
- Waspe L. E., Waxman H. L., Buxton A. E., Josephson M. E. Mexiletine for the control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients. American Journal of Cardiology 1983; 51: 1175–1181
- Williams K., Lee E. Importance of drug enantiomers in clinical pharmacology. Drugs 1985; 30: 333–354